Literature DB >> 29808791

Genetic variability in scaffolding proteins and risk for schizophrenia and autism-spectrum disorders: a systematic review.

Jordi Soler1, Lourdes Fañanás1, Mara Parellada1, Marie-Odile Krebs1, Guy A Rouleau1, Mar Fatjó-Vilas1.   

Abstract

Scaffolding proteins represent an evolutionary solution to controlling the specificity of information transfer in intracellular networks. They are highly concentrated in complexes located in specific subcellular locations. One of these complexes is the postsynaptic density of the excitatory synapses. There, scaffolding proteins regulate various processes related to synaptic plasticity, such as glutamate receptor trafficking and signalling, and dendritic structure and function. Most scaffolding proteins can be grouped into 4 main families: discs large (DLG), discs-large-associated protein (DLGAP), Shank and Homer. Owing to the importance of scaffolding proteins in postsynaptic density architecture, it is not surprising that variants in the genes that code for these proteins have been associated with neuropsychiatric diagnoses, including schizophrenia and autism-spectrum disorders. Such evidence, together with the clinical, neurobiological and genetic overlap described between schizophrenia and autism-spectrum disorders, suggest that alteration of scaffolding protein dynamics could be part of the pathophysiology of both. However, despite the potential importance of scaffolding proteins in these psychiatric conditions, no systematic review has integrated the genetic and molecular data from studies conducted in the last decade. This review has the following goals: i) to systematically analyze the literature in which common and/or rare genetic variants (single nucleotide polymorphisms, single nucleotide variants and copy number variants) in the scaffolding family genes are associated with the risk for either schizophrenia or autism-spectrum disorders; ii) to explore the implications of the reported genetic variants for gene expression and/or protein function; and iii) to discuss the relationship of these genetic variants to the shared genetic, clinical and cognitive traits of schizophrenia and autism-spectrum disorders.

Entities:  

Year:  2018        PMID: 29808791     DOI: 10.1503/jpn.170066

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  241 in total

1.  Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine.

Authors:  Daniela Polese; Antonella Amato de Serpis; Alberto Ambesi-Impiombato; Giovanni Muscettola; Andrea de Bartolomeis
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

Review 2.  MAGUKs in synapse assembly and function: an emerging view.

Authors:  J M Montgomery; P L Zamorano; C C Garner
Journal:  Cell Mol Life Sci       Date:  2004-04       Impact factor: 9.261

3.  Quaternary structure, protein dynamics, and synaptic function of SAP97 controlled by L27 domain interactions.

Authors:  Terunaga Nakagawa; Kensuke Futai; Hilal A Lashuel; Irene Lo; Kenichi Okamoto; Thomas Walz; Yasunori Hayashi; Morgan Sheng
Journal:  Neuron       Date:  2004-10-28       Impact factor: 17.173

4.  Schizophrenia in a patient with subtelomeric duplication of chromosome 22q.

Authors:  P Failla; C Romano; A Alberti; A Vasta; S Buono; L Castiglia; D Luciano; D Di Benedetto; M Fichera; O Galesi
Journal:  Clin Genet       Date:  2007-06       Impact factor: 4.438

5.  Molecular dissociation of the role of PSD-95 in regulating synaptic strength and LTD.

Authors:  Weifeng Xu; Oliver M Schlüter; Pascal Steiner; Brian L Czervionke; Bernardo Sabatini; Robert C Malenka
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

6.  Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action.

Authors:  C Tomasetti; C Dell'Aversano; F Iasevoli; A de Bartolomeis
Journal:  Neuroscience       Date:  2007-08-28       Impact factor: 3.590

7.  Opposing effects of PSD-93 and PSD-95 on long-term potentiation and spike timing-dependent plasticity.

Authors:  Holly J Carlisle; Ann E Fink; Seth G N Grant; Thomas J O'Dell
Journal:  J Physiol       Date:  2008-10-20       Impact factor: 5.182

Review 8.  Global prevalence of autism and other pervasive developmental disorders.

Authors:  Mayada Elsabbagh; Gauri Divan; Yun-Joo Koh; Young Shin Kim; Shuaib Kauchali; Carlos Marcín; Cecilia Montiel-Nava; Vikram Patel; Cristiane S Paula; Chongying Wang; Mohammad Taghi Yasamy; Eric Fombonne
Journal:  Autism Res       Date:  2012-04-11       Impact factor: 5.216

9.  Convergence of genes and cellular pathways dysregulated in autism spectrum disorders.

Authors:  Dalila Pinto; Elsa Delaby; Daniele Merico; Mafalda Barbosa; Alison Merikangas; Lambertus Klei; Bhooma Thiruvahindrapuram; Xiao Xu; Robert Ziman; Zhuozhi Wang; Jacob A S Vorstman; Ann Thompson; Regina Regan; Marion Pilorge; Giovanna Pellecchia; Alistair T Pagnamenta; Bárbara Oliveira; Christian R Marshall; Tiago R Magalhaes; Jennifer K Lowe; Jennifer L Howe; Anthony J Griswold; John Gilbert; Eftichia Duketis; Beth A Dombroski; Maretha V De Jonge; Michael Cuccaro; Emily L Crawford; Catarina T Correia; Judith Conroy; Inês C Conceição; Andreas G Chiocchetti; Jillian P Casey; Guiqing Cai; Christelle Cabrol; Nadia Bolshakova; Elena Bacchelli; Richard Anney; Steven Gallinger; Michelle Cotterchio; Graham Casey; Lonnie Zwaigenbaum; Kerstin Wittemeyer; Kirsty Wing; Simon Wallace; Herman van Engeland; Ana Tryfon; Susanne Thomson; Latha Soorya; Bernadette Rogé; Wendy Roberts; Fritz Poustka; Susana Mouga; Nancy Minshew; L Alison McInnes; Susan G McGrew; Catherine Lord; Marion Leboyer; Ann S Le Couteur; Alexander Kolevzon; Patricia Jiménez González; Suma Jacob; Richard Holt; Stephen Guter; Jonathan Green; Andrew Green; Christopher Gillberg; Bridget A Fernandez; Frederico Duque; Richard Delorme; Geraldine Dawson; Pauline Chaste; Cátia Café; Sean Brennan; Thomas Bourgeron; Patrick F Bolton; Sven Bölte; Raphael Bernier; Gillian Baird; Anthony J Bailey; Evdokia Anagnostou; Joana Almeida; Ellen M Wijsman; Veronica J Vieland; Astrid M Vicente; Gerard D Schellenberg; Margaret Pericak-Vance; Andrew D Paterson; Jeremy R Parr; Guiomar Oliveira; John I Nurnberger; Anthony P Monaco; Elena Maestrini; Sabine M Klauck; Hakon Hakonarson; Jonathan L Haines; Daniel H Geschwind; Christine M Freitag; Susan E Folstein; Sean Ennis; Hilary Coon; Agatino Battaglia; Peter Szatmari; James S Sutcliffe; Joachim Hallmayer; Michael Gill; Edwin H Cook; Joseph D Buxbaum; Bernie Devlin; Louise Gallagher; Catalina Betancur; Stephen W Scherer
Journal:  Am J Hum Genet       Date:  2014-04-24       Impact factor: 11.025

10.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.

Authors:  Brian J O'Roak; Pelagia Deriziotis; Choli Lee; Laura Vives; Jerrod J Schwartz; Santhosh Girirajan; Emre Karakoc; Alexandra P Mackenzie; Sarah B Ng; Carl Baker; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Simon E Fisher; Jay Shendure; Evan E Eichler
Journal:  Nat Genet       Date:  2011-05-15       Impact factor: 38.330

View more
  4 in total

1.  A study of normal copy number variations in Israeli population.

Authors:  Idit Maya; Pola Smirin-Yosef; Sarit Kahana; Sne Morag; Shiri Yacobson; Ifaat Agmon-Fishman; Reut Matar; Elisheva Bitton; Mordechai Shohat; Lina Basel-Salmon; Mali Salmon-Divon
Journal:  Hum Genet       Date:  2020-09-27       Impact factor: 4.132

2.  Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIα-Shank3 Interaction.

Authors:  Tyler L Perfitt; Xiaohan Wang; Matthew T Dickerson; Jason R Stephenson; Terunaga Nakagawa; David A Jacobson; Roger J Colbran
Journal:  J Neurosci       Date:  2020-02-04       Impact factor: 6.167

3.  Genetic risk factors for autism-spectrum disorders: a systematic review based on systematic reviews and meta-analysis.

Authors:  Hongyuan Wei; Yunjiao Zhu; Tianli Wang; Xueqing Zhang; Kexin Zhang; Zhihua Zhang
Journal:  J Neural Transm (Vienna)       Date:  2021-06-11       Impact factor: 3.575

Review 4.  Cannabis Exposure During Critical Windows of Development: Epigenetic and Molecular Pathways Implicated in Neuropsychiatric Disease.

Authors:  Anna Smith; Farla Kaufman; Martha S Sandy; Andres Cardenas
Journal:  Curr Environ Health Rep       Date:  2020-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.